 | • レポートコード：MRC2-11QY04539 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は風疹診断検査のグローバル市場について調査・分析したレポートです。種類別（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価）市場規模、用途別（病院、商業、診療所、保健所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別風疹診断検査の競争状況、市場シェア ・世界の風疹診断検査市場：種類別市場規模 2015年-2020年（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価） ・世界の風疹診断検査市場：種類別市場規模予測 2021年-2026年（フローサイトメトリー、ラテックススライド凝集反応、モノクローナル抗体、イムノアッセイ、血清学的検査、臨床評価） ・世界の風疹診断検査市場：用途別市場規模 2015年-2020年（病院、商業、診療所、保健所、その他） ・世界の風疹診断検査市場：用途別市場規模予測 2021年-2026年（病院、商業、診療所、保健所、その他） ・北米の風疹診断検査市場分析：米国、カナダ ・ヨーロッパの風疹診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの風疹診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の風疹診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの風疹診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Beckman Coulter、Bio Rad Laboratories、Biogate Laboratories、BioMerieux SA、Cigna、Diagnostic Laboratory of Oklahoma、GlaxoSmithKline、HealthLink BC、Mayo Clinic、Ortho Clinical Diagnostics、True Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Rubella infection generally affects children and adults. This infection has a serious effect on pregnant women and may result in fetal death or congenital defects.
Geographically, the entire rubella diagnostic testing market is classified into North America, Europe, Asia Pacific, Latin America and MEA.
Market Analysis and Insights: Global Rubella Diagnostic Testing Market
The global Rubella Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rubella Diagnostic Testing Scope and Market Size
Rubella Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rubella Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Beckman Coulter
Bio Rad Laboratories
Biogate Laboratories
BioMerieux SA
Cigna
Diagnostic Laboratory of Oklahoma
GlaxoSmithKline
HealthLink BC
Mayo Clinic
Ortho Clinical Diagnostics
True Health
Market segment by Type, the product can be split into
Flow Cytometry
Latex Slide Agglutination Test
Monoclonal Antibodies
Immunoassays
Serological Testing
Clinical Evaluation
Market segment by Application, split into
Hospitals
Commercial
Physician Offices
Public Health Labs
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rubella Diagnostic Testing Revenue
1.4 Market by Type
1.4.1 Global Rubella Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Flow Cytometry
1.4.3 Latex Slide Agglutination Test
1.4.4 Monoclonal Antibodies
1.4.5 Immunoassays
1.4.6 Serological Testing
1.4.7 Clinical Evaluation
1.5 Market by Application
1.5.1 Global Rubella Diagnostic Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Commercial
1.5.4 Physician Offices
1.5.5 Public Health Labs
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Rubella Diagnostic Testing Market Perspective (2015-2026)
2.2 Global Rubella Diagnostic Testing Growth Trends by Regions
2.2.1 Rubella Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rubella Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Rubella Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rubella Diagnostic Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Rubella Diagnostic Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Rubella Diagnostic Testing Players by Market Size
3.1.1 Global Top Rubella Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global Rubella Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Rubella Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rubella Diagnostic Testing Market Concentration Ratio
3.2.1 Global Rubella Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rubella Diagnostic Testing Revenue in 2019
3.3 Rubella Diagnostic Testing Key Players Head office and Area Served
3.4 Key Players Rubella Diagnostic Testing Product Solution and Service
3.5 Date of Enter into Rubella Diagnostic Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rubella Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global Rubella Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Rubella Diagnostic Testing Market Size by Application (2015-2020)
5.2 Global Rubella Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Rubella Diagnostic Testing Market Size (2015-2020)
6.2 Rubella Diagnostic Testing Key Players in North America (2019-2020)
6.3 North America Rubella Diagnostic Testing Market Size by Type (2015-2020)
6.4 North America Rubella Diagnostic Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Rubella Diagnostic Testing Market Size (2015-2020)
7.2 Rubella Diagnostic Testing Key Players in Europe (2019-2020)
7.3 Europe Rubella Diagnostic Testing Market Size by Type (2015-2020)
7.4 Europe Rubella Diagnostic Testing Market Size by Application (2015-2020)
8 China
8.1 China Rubella Diagnostic Testing Market Size (2015-2020)
8.2 Rubella Diagnostic Testing Key Players in China (2019-2020)
8.3 China Rubella Diagnostic Testing Market Size by Type (2015-2020)
8.4 China Rubella Diagnostic Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Rubella Diagnostic Testing Market Size (2015-2020)
9.2 Rubella Diagnostic Testing Key Players in Japan (2019-2020)
9.3 Japan Rubella Diagnostic Testing Market Size by Type (2015-2020)
9.4 Japan Rubella Diagnostic Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Rubella Diagnostic Testing Market Size (2015-2020)
10.2 Rubella Diagnostic Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rubella Diagnostic Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Rubella Diagnostic Testing Market Size by Application (2015-2020)
11 India
11.1 India Rubella Diagnostic Testing Market Size (2015-2020)
11.2 Rubella Diagnostic Testing Key Players in India (2019-2020)
11.3 India Rubella Diagnostic Testing Market Size by Type (2015-2020)
11.4 India Rubella Diagnostic Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Rubella Diagnostic Testing Market Size (2015-2020)
12.2 Rubella Diagnostic Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Rubella Diagnostic Testing Market Size by Type (2015-2020)
12.4 Central & South America Rubella Diagnostic Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Rubella Diagnostic Testing Introduction
13.1.4 Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Beckman Coulter
13.2.1 Beckman Coulter Company Details
13.2.2 Beckman Coulter Business Overview
13.2.3 Beckman Coulter Rubella Diagnostic Testing Introduction
13.2.4 Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.2.5 Beckman Coulter Recent Development
13.3 Bio Rad Laboratories
13.3.1 Bio Rad Laboratories Company Details
13.3.2 Bio Rad Laboratories Business Overview
13.3.3 Bio Rad Laboratories Rubella Diagnostic Testing Introduction
13.3.4 Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.3.5 Bio Rad Laboratories Recent Development
13.4 Biogate Laboratories
13.4.1 Biogate Laboratories Company Details
13.4.2 Biogate Laboratories Business Overview
13.4.3 Biogate Laboratories Rubella Diagnostic Testing Introduction
13.4.4 Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.4.5 Biogate Laboratories Recent Development
13.5 BioMerieux SA
13.5.1 BioMerieux SA Company Details
13.5.2 BioMerieux SA Business Overview
13.5.3 BioMerieux SA Rubella Diagnostic Testing Introduction
13.5.4 BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.5.5 BioMerieux SA Recent Development
13.6 Cigna
13.6.1 Cigna Company Details
13.6.2 Cigna Business Overview
13.6.3 Cigna Rubella Diagnostic Testing Introduction
13.6.4 Cigna Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.6.5 Cigna Recent Development
13.7 Diagnostic Laboratory of Oklahoma
13.7.1 Diagnostic Laboratory of Oklahoma Company Details
13.7.2 Diagnostic Laboratory of Oklahoma Business Overview
13.7.3 Diagnostic Laboratory of Oklahoma Rubella Diagnostic Testing Introduction
13.7.4 Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.7.5 Diagnostic Laboratory of Oklahoma Recent Development
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Details
13.8.2 GlaxoSmithKline Business Overview
13.8.3 GlaxoSmithKline Rubella Diagnostic Testing Introduction
13.8.4 GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.8.5 GlaxoSmithKline Recent Development
13.9 HealthLink BC
13.9.1 HealthLink BC Company Details
13.9.2 HealthLink BC Business Overview
13.9.3 HealthLink BC Rubella Diagnostic Testing Introduction
13.9.4 HealthLink BC Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.9.5 HealthLink BC Recent Development
13.10 Mayo Clinic
13.10.1 Mayo Clinic Company Details
13.10.2 Mayo Clinic Business Overview
13.10.3 Mayo Clinic Rubella Diagnostic Testing Introduction
13.10.4 Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2015-2020)
13.10.5 Mayo Clinic Recent Development
13.11 Ortho Clinical Diagnostics
10.11.1 Ortho Clinical Diagnostics Company Details
10.11.2 Ortho Clinical Diagnostics Business Overview
10.11.3 Ortho Clinical Diagnostics Rubella Diagnostic Testing Introduction
10.11.4 Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2015-2020)
10.11.5 Ortho Clinical Diagnostics Recent Development
13.12 True Health
10.12.1 True Health Company Details
10.12.2 True Health Business Overview
10.12.3 True Health Rubella Diagnostic Testing Introduction
10.12.4 True Health Revenue in Rubella Diagnostic Testing Business (2015-2020)
10.12.5 True Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Rubella Diagnostic Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Rubella Diagnostic Testing Revenue
Table 3. Ranking of Global Top Rubella Diagnostic Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rubella Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Flow Cytometry
Table 6. Key Players of Latex Slide Agglutination Test
Table 7. Key Players of Monoclonal Antibodies
Table 8. Key Players of Immunoassays
Table 9. Key Players of Serological Testing
Table 10. Key Players of Clinical Evaluation
Table 11. Global Rubella Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Rubella Diagnostic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Rubella Diagnostic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Rubella Diagnostic Testing Market Share by Regions (2015-2020)
Table 15. Global Rubella Diagnostic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Rubella Diagnostic Testing Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Rubella Diagnostic Testing Market Growth Strategy
Table 21. Main Points Interviewed from Key Rubella Diagnostic Testing Players
Table 22. Global Rubella Diagnostic Testing Revenue by Players (2015-2020) (Million US$)
Table 23. Global Rubella Diagnostic Testing Market Share by Players (2015-2020)
Table 24. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rubella Diagnostic Testing as of 2019)
Table 25. Global Rubella Diagnostic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Rubella Diagnostic Testing Product Solution and Service
Table 28. Date of Enter into Rubella Diagnostic Testing Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 31. Global Rubella Diagnostic Testing Market Size Share by Type (2015-2020)
Table 32. Global Rubella Diagnostic Testing Revenue Market Share by Type (2021-2026)
Table 33. Global Rubella Diagnostic Testing Market Size Share by Application (2015-2020)
Table 34. Global Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 35. Global Rubella Diagnostic Testing Market Size Share by Application (2021-2026)
Table 36. North America Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 38. North America Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 39. North America Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 40. North America Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 41. North America Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 42. Europe Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 44. Europe Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 46. Europe Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 48. China Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 49. China Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 50. China Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 51. China Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 52. China Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 53. China Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 54. Japan Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 56. Japan Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 58. Japan Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 62. Southeast Asia Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 64. Southeast Asia Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 66. India Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 67. India Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 68. India Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 69. India Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 70. India Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 71. India Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Rubella Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Rubella Diagnostic Testing Market Share (2019-2020)
Table 74. Central & South America Rubella Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Rubella Diagnostic Testing Market Share by Type (2015-2020)
Table 76. Central & South America Rubella Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Rubella Diagnostic Testing Market Share by Application (2015-2020)
Table 78. Abbott Laboratories Company Details
Table 79. Abbott Laboratories Business Overview
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 82. Abbott Laboratories Recent Development
Table 83. Beckman Coulter Company Details
Table 84. Beckman Coulter Business Overview
Table 85. Beckman Coulter Product
Table 86. Beckman Coulter Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 87. Beckman Coulter Recent Development
Table 88. Bio Rad Laboratories Company Details
Table 89. Bio Rad Laboratories Business Overview
Table 90. Bio Rad Laboratories Product
Table 91. Bio Rad Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 92. Bio Rad Laboratories Recent Development
Table 93. Biogate Laboratories Company Details
Table 94. Biogate Laboratories Business Overview
Table 95. Biogate Laboratories Product
Table 96. Biogate Laboratories Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 97. Biogate Laboratories Recent Development
Table 98. BioMerieux SA Company Details
Table 99. BioMerieux SA Business Overview
Table 100. BioMerieux SA Product
Table 101. BioMerieux SA Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 102. BioMerieux SA Recent Development
Table 103. Cigna Company Details
Table 104. Cigna Business Overview
Table 105. Cigna Product
Table 106. Cigna Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 107. Cigna Recent Development
Table 108. Diagnostic Laboratory of Oklahoma Company Details
Table 109. Diagnostic Laboratory of Oklahoma Business Overview
Table 110. Diagnostic Laboratory of Oklahoma Product
Table 111. Diagnostic Laboratory of Oklahoma Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 112. Diagnostic Laboratory of Oklahoma Recent Development
Table 113. GlaxoSmithKline Business Overview
Table 114. GlaxoSmithKline Product
Table 115. GlaxoSmithKline Company Details
Table 116. GlaxoSmithKline Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 117. GlaxoSmithKline Recent Development
Table 118. HealthLink BC Company Details
Table 119. HealthLink BC Business Overview
Table 120. HealthLink BC Product
Table 121. HealthLink BC Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 122. HealthLink BC Recent Development
Table 123. Mayo Clinic Company Details
Table 124. Mayo Clinic Business Overview
Table 125. Mayo Clinic Product
Table 126. Mayo Clinic Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 127. Mayo Clinic Recent Development
Table 128. Ortho Clinical Diagnostics Company Details
Table 129. Ortho Clinical Diagnostics Business Overview
Table 130. Ortho Clinical Diagnostics Product
Table 131. Ortho Clinical Diagnostics Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 132. Ortho Clinical Diagnostics Recent Development
Table 133. True Health Company Details
Table 134. True Health Business Overview
Table 135. True Health Product
Table 136. True Health Revenue in Rubella Diagnostic Testing Business (2015-2020) (Million US$)
Table 137. True Health Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rubella Diagnostic Testing Market Share by Type: 2020 VS 2026
Figure 2. Flow Cytometry Features
Figure 3. Latex Slide Agglutination Test Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Immunoassays Features
Figure 6. Serological Testing Features
Figure 7. Clinical Evaluation Features
Figure 8. Global Rubella Diagnostic Testing Market Share by Application: 2020 VS 2026
Figure 9. Hospitals Case Studies
Figure 10. Commercial Case Studies
Figure 11. Physician Offices Case Studies
Figure 12. Public Health Labs Case Studies
Figure 13. Other Case Studies
Figure 14. Rubella Diagnostic Testing Report Years Considered
Figure 15. Global Rubella Diagnostic Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Rubella Diagnostic Testing Market Share by Regions: 2020 VS 2026
Figure 17. Global Rubella Diagnostic Testing Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Rubella Diagnostic Testing Market Share by Players in 2019
Figure 20. Global Top Rubella Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rubella Diagnostic Testing as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Rubella Diagnostic Testing Revenue in 2019
Figure 22. North America Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Rubella Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
免疫タンパク質診断検査の世界市場（～2026年） Immunoprotein is an immunologically active protein, which provides immunity against pathogenic organisms or substances. These proteins form the integrated body system of tissues, organs, cells, or cell products that neutralize antigens. They enable the diagnosis of various diseases, such as cardiova…- 豚診断検査の世界市場（～2026年） Swine diagnostic testing is extremely important for pork breeders to keep adverse effects on production and minimum economic losses. Growing consumption of pork meat is expected to be the prime factor driving the growth of global swine diagnostic testing market. Market Analysis and Insights: Global …
- 大腸菌（Eコリ）診断検査の世界市場（～2026年） Escherichia coli (E. coli), is a bacterium which normally lives in the intestines of humans and animals. Major sign and symptoms of E. coli infection include abdominal pain, diarrhea, and nausea and vomiting. Cases of E. coli infection are usually confirmed by the detection of bacteria in stool samp…
- 髄膜炎診断検査の世界市場（～2026年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …
- 子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…